Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review.
J Neurol
; 268(11): 3947-3960, 2021 Nov.
Article
Dans Anglais
| MEDLINE | ID: covidwho-1237497
ABSTRACT
BACKGROUND:
The COVID-19 pandemic leads to disruptions of health services worldwide. To evaluate the particular impact on neurological services a rapid review was conducted.METHODS:
Studies reporting the provision of neurological services during the pandemic and/or adopted mitigation strategies were included in this review. PubMed and World Health Organization's (WHO) COVID-19 database were searched. Data extraction followed categories used by WHO COVID-19 pulse surveys and operational guidelines on maintaining essential health services during COVID-19.FINDINGS:
The search yielded 1101 articles, of which 369 fulfilled eligibility criteria, describing data from 210,419 participants, being adults (81%), children (11.4%) or both (7.3%). Included articles reported data from 105 countries and territories covering all WHO regions and World Bank income levels (low income 1.9%, lower middle 24.7%, upper middle 29.5% and high income; 44.8%). Cross-sectoral services for neurological disorders were most frequently disrupted (62.9%), followed by emergency/acute care (47.1%). The degree of disruption was at least moderate for 75% of studies. Travel restrictions due to lockdowns (81.7%) and regulatory closure of services (65.4%) were the most commonly reported causes of disruption. Authors most frequently described telemedicine (82.1%) and novel dispensing approaches for medicines (51.8%) as mitigation strategies. Evidence for the effectiveness of these measures is largely missing.INTERPRETATION:
The COVID-19 pandemic affects all aspects of neurological care. Given the worldwide prevalence of neurological disorders and the potential long-term neurological consequences of COVID-19, service disruptions are devastating. Different strategies such as telemedicine might mitigate the negative effects of the pandemic, but their efficacy and acceptability remain to be seen.Mots clés
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Sujet Principal:
Télémédecine
/
COVID-19
Type d'étude:
Études expérimentales
/
Étude observationnelle
/
Essai contrôlé randomisé
/
Révision
Limites du sujet:
Adulte
/
Enfant
/
Humains
langue:
Anglais
Revue:
J Neurol
Année:
2021
Type de document:
Article
Pays d'affiliation:
S00415-021-10588-5
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS